🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with numerous of members share comparison images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, doctors and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.

Several professionals stated the demand for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking fines, legal action or imprisonment.

Service Response and Material Elimination

Based on the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Research also found communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at residence.

Within minutes of entering one community, a vendor shared contact information, where most purchases take place. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Product Information and Pricing

Within these communities, posts show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram stated it actively monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Even if the science behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has previously seen patients harmed by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to potentially significant health risks”.